by studio | Mar 1, 2017 | News
Here at ViCentra, we’re delighted to announce that we have recently signed an agreement with Bosman Medical Supplies, part of OneMed, for distribution of the Kaleido insulin pump across the Netherlands. This exclusive deal with one of the Netherlands’ largest...
by studio | Sep 9, 2016 | News
ViCentra, manufacturer of the Kaleido insulin delivery system, today announced the appointment of Dr. David Kerr and Dr. Fred Storms as medical and scientific advisors to its team. Drs. Kerr and Storms are both internationally recognised experts in the treatment of...
by studio | May 10, 2016 | News
ViCentra today announced that Remmert Laan, President of specialist diabetes consultancy, Diabetes Insights, LLC, has joined the ViCentra Board as a Non-executive Board Member. Prior to launching Diabetes Insights, LLC in 2015, Rem held the position of Executive...
by studio | Apr 15, 2016 | News
In anticipation of the imminent commercialisation of the Kaleido insulin delivery system, the ViCentra Board are announcing today a change in management that prepares the Company for the next phase in its future. Joseph Cefai stepped down as CEO on April 1st 2016....
by studio | Jan 20, 2016 | News
January 16th, 2016. LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series B Round of ViCentra B.V., a private Dutch company commercializing the Kaleido insulin pump system for people with diabetes. The...
Recent Comments